Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.17 USD
Change Today -0.006 / -3.41%
Volume 284.5K
APHB On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

ampliphi biosciences corp (APHB) Snapshot

Open
$0.18
Previous Close
$0.18
Day High
$0.18
Day Low
$0.17
52 Week High
05/23/14 - $0.50
52 Week Low
10/14/14 - $0.07
Market Cap
48.3M
Average Volume 10 Days
768.7K
EPS TTM
$-0.09
Shares Outstanding
284.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMPLIPHI BIOSCIENCES CORP (APHB)

Related News

No related news articles were found.

ampliphi biosciences corp (APHB) Related Businessweek News

No Related Businessweek News Found

ampliphi biosciences corp (APHB) Details

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of various bacteriophage therapeutics. The company’s lead programs include AmpliPhage-001 for the treatment of cystic fibrosis patients with P. aeruginosa lung infections; AmpliPhage-002 for the treatment of methicillin-resistant S. aureus infections; and AmpliPhage-004 for the treatment of C. difficile infections. It has a collaboration agreement with Intrexon Corporation to utilize synthetic biology platform for the identification, development, and production of bacteriophage-containing human therapeutics. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is headquartered in Glen Allen, Virginia.

18 Employees
Last Reported Date: 05/12/15
Founded in 1989

ampliphi biosciences corp (APHB) Top Compensated Officers

Interim Chief Financial Officer
Total Annual Compensation: $127.1K
Interim Chief Operating Officer and Director
Total Annual Compensation: $60.0K
Chief Scientific Officer
Total Annual Compensation: $225.5K
Compensation as of Fiscal Year 2014.

ampliphi biosciences corp (APHB) Key Developments

Ampliphi Biosciences Corporation Announces Management Changes, Effective May 18, 2015

AmpliPhi BioSciences Corporation announced that M. Scott Salka has been appointed as the new CEO. Mr. Salka will replace Interim CEO and Chairman of AmpliPhi, Jeremy Curnock Cook, effective May 18. Mr. Curnock Cook will remain in his role as Chairman. Since 2010, Mr. Salka has served as CEO of Aspyrian Therapeutics Inc. Prior to this role, he was the CEO of Ambit Biosciences.

AmpliPhi Biosciences Corporation announced delayed annual 10-K filing

On 03/31/2015, AmpliPhi Biosciences Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.

AmpliPhi Biosciences Corporation Presents at 27th Annual ROTH Conference, Mar-09-2015 04:00 PM

AmpliPhi Biosciences Corporation Presents at 27th Annual ROTH Conference, Mar-09-2015 04:00 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APHB:US $0.17 USD -0.006

APHB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for APHB.
View Industry Companies
 

Industry Analysis

APHB

Industry Average

Valuation APHB Industry Range
Price/Earnings 2.6x
Price/Sales 84.3x
Price/Book 10.2x
Price/Cash Flow 2.1x
TEV/Sales 70.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMPLIPHI BIOSCIENCES CORP, please visit www.ampliphibio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.